BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Autoimmunity, Ciprofibrate, rs3825942, NEUROG3, nitric oxide metabolic process)
Bookmark Forward

QuickView for AK4;jsessionid=8B9C79EDA86DEA190719809C1CD6E94D;jsessionid=2D18E824BFC828C457F5CF66F27481D6;jsessionid=A078C97EBF7AD381382515C210DA11AE;jsessionid=5E0BE3D9C3D87C779AA87C04BC29F3CB;jsessionid=F2E142406B850B669303A3DD7998F0E6;jsessionid=4F8B1FF82ACCD35EAF55E6795BA01046 (gene)


Body Atlas

Most Correlated Tissues

  1. Kidney cortex
  2. Kidney
  3. Kidney medulla
  4. Liver
  5. Fetal liver
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hypoxia
  2. Tularemia
  3. Injury of eye region
  4. Lyme disease
  5. Infection by Schistosoma
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Berberine
  2. Antibodies, Neutralizing
  3. cobaltous chloride
  4. 2-nitroanisole
  5. Auranofin
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. hsa-miR-31-5p
  2. Gjd2
  3. RAB1B
  4. CRYAB
  5. EGR2
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for AK4;jsessionid=8B9C79EDA86DEA190719809C1CD6E94D;jsessionid=2D18E824BFC828C457F5CF66F27481D6;jsessionid=A078C97EBF7AD381382515C210DA11AE;jsessionid=5E0BE3D9C3D87C779AA87C04BC29F3CB;jsessionid=F2E142406B850B669303A3DD7998F0E6;jsessionid=4F8B1FF82ACCD35EAF55E6795BA01046
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for AK4;jsessionid=8B9C79EDA86DEA190719809C1CD6E94D;jsessionid=2D18E824BFC828C457F5CF66F27481D6;jsessionid=A078C97EBF7AD381382515C210DA11AE;jsessionid=5E0BE3D9C3D87C779AA87C04BC29F3CB;jsessionid=F2E142406B850B669303A3DD7998F0E6;jsessionid=4F8B1FF82ACCD35EAF55E6795BA01046
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.